Hope for MSA: new drug aims to slow rare brain disease
Disease control
Recruiting now
This study tests a new drug called MSA-01 to see if it can slow the worsening of multiple system atrophy (MSA), a rare and serious brain disease. About 140 people with MSA will get either MSA-01 or a placebo for 12 months. The main goal is to measure changes in movement and daily…
Phase: PHASE3 • Sponsor: Tokyo University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC